These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24726912)
1. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells. Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912 [TBL] [Abstract][Full Text] [Related]
2. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809 [TBL] [Abstract][Full Text] [Related]
3. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173 [TBL] [Abstract][Full Text] [Related]
4. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743 [TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma. Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151 [TBL] [Abstract][Full Text] [Related]
6. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419 [TBL] [Abstract][Full Text] [Related]
7. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
8. Modulation of c-kit expression in pancreatic adenocarcinoma: a novel stem cell marker responsible for the progression of the disease. Amsterdam A; Raanan C; Polin N; Melzer E; Givol D; Schreiber L Acta Histochem; 2014 Jan; 116(1):197-203. PubMed ID: 23978330 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992 [TBL] [Abstract][Full Text] [Related]
10. ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells. Sainz B; Martín B; Tatari M; Heeschen C; Guerra S Cancer Res; 2014 Dec; 74(24):7309-20. PubMed ID: 25368022 [TBL] [Abstract][Full Text] [Related]
11. Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes. Ai J; Wörmann SM; Görgülü K; Vallespinos M; Zagorac S; Alcala S; Wu N; Kabacaoglu D; Berninger A; Navarro D; Kaya-Aksoy E; Ruess DA; Ciecielski KJ; Kowalska M; Demir IE; Ceyhan GO; Heid I; Braren R; Riemann M; Schreiner S; Hofmann S; Kutschke M; Jastroch M; Slotta-Huspenina J; Muckenhuber A; Schlitter AM; Schmid RM; Steiger K; Diakopoulos KN; Lesina M; Sainz B; Algül H Gastroenterology; 2021 Jul; 161(1):318-332.e9. PubMed ID: 33819482 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells. Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497 [TBL] [Abstract][Full Text] [Related]
13. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma. Song W; Li Q; Wang L; Huang W; Wang L Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418 [TBL] [Abstract][Full Text] [Related]
14. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077 [TBL] [Abstract][Full Text] [Related]
15. Reduced retinoids and retinoid receptors' expression in pancreatic cancer: A link to patient survival. Bleul T; Rühl R; Bulashevska S; Karakhanova S; Werner J; Bazhin AV Mol Carcinog; 2015 Sep; 54(9):870-9. PubMed ID: 24729540 [TBL] [Abstract][Full Text] [Related]
16. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer stem cells: A state or an entity? Hermann PC; Sainz B Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664 [TBL] [Abstract][Full Text] [Related]
18. Biology and clinical applications of pancreatic cancer stem cells. Abel EV; Simeone DM Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133 [TBL] [Abstract][Full Text] [Related]